Add to ORKGAcute leukemia is a constellation of rapidly progressing diseases that affect a wide range of patients regardless of age or gender. Traditional treatment options for patients with acute leukemia include chemotherapy and hematopoietic cell transplantation. The advent of cancer immunotherapy has had a significant impact on acute leukemia treatment. Novel immunotherapeutic agents including antibody-drug conjugates, bispecific T cell engagers, and chimeric antigen receptor T cell therapies have efficacy and have recently been approved by the US Food and Drug Administration (FDA) for the treatment of patients with acute leukemia. The Society for Immunotherapy of Cancer (SITC) convened a panel of experts to develop a clinical practice guideline c...
Recent developments in immunotherapy are improving treatment results of B-precursor acute lymphoblas...
With recent clinical breakthroughs, immunotherapy has become the fourth pillar of cancer treatment. ...
Abstract The advent of new immunotherapeutic agents in clinical practice has revolutionized cancer t...
Acute leukemia is a constellation of rapidly progressing diseases that affect a wide range of patien...
Acute leukemia is a constellation of rapidly progressing diseases that affect a wide range of patien...
Increasing knowledge concerning the biology of hematologic malignancies as well as the role of the i...
The efficacy of immunotherapeutic approaches in the treatment of different cancer types is becoming ...
The treatment of acute myeloid leukemia (AML) did not evolve profoundly in the last decades. Some im...
The recent development and clinical implementation of novel immunotherapies for the treatment of Hod...
The recent development and clinical implementation of novel immunotherapies for the treatment of Hod...
Increasing knowledge concerning the biology of hematologic malignancies as well as the role of the i...
Chemotherapy has been dominating the field of cancer treatment for a long time, however, its limitat...
The development and design of immune-based strategies have become an increasingly important topic du...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The standard of care in me...
International audienceAcute leukemias are characterized by accumulation of immature cells (blasts) a...
Recent developments in immunotherapy are improving treatment results of B-precursor acute lymphoblas...
With recent clinical breakthroughs, immunotherapy has become the fourth pillar of cancer treatment. ...
Abstract The advent of new immunotherapeutic agents in clinical practice has revolutionized cancer t...
Acute leukemia is a constellation of rapidly progressing diseases that affect a wide range of patien...
Acute leukemia is a constellation of rapidly progressing diseases that affect a wide range of patien...
Increasing knowledge concerning the biology of hematologic malignancies as well as the role of the i...
The efficacy of immunotherapeutic approaches in the treatment of different cancer types is becoming ...
The treatment of acute myeloid leukemia (AML) did not evolve profoundly in the last decades. Some im...
The recent development and clinical implementation of novel immunotherapies for the treatment of Hod...
The recent development and clinical implementation of novel immunotherapies for the treatment of Hod...
Increasing knowledge concerning the biology of hematologic malignancies as well as the role of the i...
Chemotherapy has been dominating the field of cancer treatment for a long time, however, its limitat...
The development and design of immune-based strategies have become an increasingly important topic du...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The standard of care in me...
International audienceAcute leukemias are characterized by accumulation of immature cells (blasts) a...
Recent developments in immunotherapy are improving treatment results of B-precursor acute lymphoblas...
With recent clinical breakthroughs, immunotherapy has become the fourth pillar of cancer treatment. ...
Abstract The advent of new immunotherapeutic agents in clinical practice has revolutionized cancer t...